ABOUT THIS FUND
Under normal circumstances, the fund will invest at least 80% of the fund’s net assets (plus borrowings for investment purposes) in U.S. and foreign exchange-listed equity securities of healthcare technology companies and American Depository Receipts (“ADRs”) on those securities. These securities may be of any market capitalization. The fund is non-diversified.
PRICE
$10.15 ▼ DOWN 0.68% (−$0.07)HOLDINGS
TOP 20 OF 28 · 87.82% OF THE FUNDRANK STOCK WEIGHT SHARES VALUE